Parathyroid adenoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Parathyroid adenoma}} {{CMG}}; {{AE}} ==Overview== If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifesta...")
 
Line 2: Line 2:
{{Parathyroid adenoma}}
{{Parathyroid adenoma}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}{{Anmol}}  


==Overview==
==Overview==
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


===Natural History===
===Natural History===
*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
*Parathyroid adenoma usually presents as asymptomatic [[hypercalcemia]] in presence of increased [[parathyroid hormone]].
*The symptoms of (disease name) typically develop ___ years after exposure to ___.  
*If left untreated, some of the patients with parathyroid adenoma may develop marked [[hypercalcemia]], [[hypercalciuria]], [[cortical bone]] demineralization and [[nephrolithiasis]].<ref name="pmid12412783">{{cite journal |vauthors=Peacock M |title=Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum |journal=J. Bone Miner. Res. |volume=17 Suppl 2 |issue= |pages=N87–94 |year=2002 |pmid=12412783 |doi= |url=}}</ref><ref name="pmid2763869">{{cite journal |vauthors=Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV |title=Skeletal disease in primary hyperparathyroidism |journal=J. Bone Miner. Res. |volume=4 |issue=3 |pages=283–91 |year=1989 |pmid=2763869 |doi=10.1002/jbmr.5650040302 |url=}}</ref>
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].


===Complications===
===Complications===
*Common complications of [disease name] include:
Organ system specific complication caused by primary hyperparathyroidism due to parathyroid adenoma include:
**[Complication 1]
**[Complication 2]
**[Complication 3]


{|
| style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|'''Complications involving Organ system'''}}
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|'''Complications due to Primary Hyperparathyroidism'''}}
|-
! style="background: #F0FFFF; text-align: center;" |Cardiaovascular complications
<ref name="pmid89892422">{{cite journal |vauthors=Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B |title=Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up |journal=J. Clin. Endocrinol. Metab. |volume=82 |issue=1 |pages=106–12 |year=1997 |pmid=8989242 |doi=10.1210/jcem.82.1.3666 |url=}}</ref><ref name="pmid112565212">{{cite journal |vauthors=Strózecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Włodarczyk Z, Manitius J |title=Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients |journal=Ren Fail |volume=23 |issue=1 |pages=115–26 |year=2001 |pmid=11256521 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Aortic valve calcification|Aortic]] and [[mitral valve calcification]]
*Calcific deposits in the [[myocardium]]
*[[Left ventricular hypertrophy]]
|-
! style="background: #F0FFFF; text-align: center;" |Endocrine complications<ref name="pmid228748072">{{cite journal |vauthors=Bai HX, Giefer M, Patel M, Orabi AI, Husain SZ |title=The association of primary hyperparathyroidism with pancreatitis |journal=J. Clin. Gastroenterol. |volume=46 |issue=8 |pages=656–61 |year=2012 |pmid=22874807 |pmc=4428665 |doi=10.1097/MCG.0b013e31825c446c |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Pancreatitis]]
|-
! style="background: #F0FFFF; text-align: center;" |Gastrointestinal complications<ref name="pmid38780022">{{cite journal |vauthors=Corlew DS, Bryda SL, Bradley EL, DiGirolamo M |title=Observations on the course of untreated primary hyperparathyroidism |journal=Surgery |volume=98 |issue=6 |pages=1064–71 |year=1985 |pmid=3878002 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Peptic ulcer disease]]
|-
! style="background: #F0FFFF; text-align: center;" |Metabolic complications
<ref name="pmid38125202">{{cite journal |vauthors=Fitzpatrick LA, Bilezikian JP |title=Acute primary hyperparathyroidism |journal=Am. J. Med. |volume=82 |issue=2 |pages=275–82 |year=1987 |pmid=3812520 |doi= |url=}}</ref><ref name="pmid254476242">{{cite journal |vauthors=Ahmad S, Kuraganti G, Steenkamp D |title=Hypercalcemic crisis: a clinical review |journal=Am. J. Med. |volume=128 |issue=3 |pages=239–45 |year=2015 |pmid=25447624 |doi=10.1016/j.amjmed.2014.09.030 |url=}}</ref><ref name="pmid38780022" /><ref name="pmid114935802">{{cite journal| author=Lips P| title=Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. | journal=Endocr Rev | year= 2001 | volume= 22 | issue= 4 | pages= 477-501 | pmid=11493580 | doi=10.1210/edrv.22.4.0437 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11493580  }}</ref><ref name="pmid222583992">{{cite journal |vauthors=Saab G, Whaley-Connell A, Bombeck A, Kurella Tamura M, Li S, Chen SC, McFarlane SI, Sowers JR, Norris K, Bakris GL, McCullough PA |title=The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease |journal=Cardiorenal Med |volume=1 |issue=2 |pages=123–130 |year=2011 |pmid=22258399 |pmc=3101512 |doi=10.1159/000327149 |url=}}</ref><ref name="HjelmesæthHofsø20092">{{cite journal|last1=Hjelmesæth|first1=Jøran|last2=Hofsø|first2=Dag|last3=Aasheim|first3=Erlend T|last4=Jenssen|first4=Trond|last5=Moan|first5=Johan|last6=Hager|first6=Helle|last7=Røislien|first7=Jo|last8=Bollerslev|first8=Jens|title=Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study|journal=Cardiovascular Diabetology|volume=8|issue=1|year=2009|pages=7|issn=1475-2840|doi=10.1186/1475-2840-8-7}}</ref><ref name="pmid94517342">{{cite journal |vauthors=Barbur MA, Kurjak M, Becker K |title=[Systematic calciphylaxis in chronic renal failure: fulminant course after kidney transplantation] |language=German |journal=Pathologe |volume=18 |issue=6 |pages=453–8 |year=1997 |pmid=9451734 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Hypercalcemic]] crisis
*[[Osteomalacia]]
|-
! style="background: #F0FFFF; text-align: center;" |Musculo-skeletal complications
<ref name="pmid251660472">{{cite journal |vauthors=Bandeira F, Cusano NE, Silva BC, Cassibba S, Almeida CB, Machado VC, Bilezikian JP |title=Bone disease in primary hyperparathyroidism |journal=Arq Bras Endocrinol Metabol |volume=58 |issue=5 |pages=553–61 |year=2014 |pmid=25166047 |pmc=4315357 |doi= |url=}}</ref><ref name="pmid98017322">{{cite journal |vauthors=Mazzuoli GF, D'Erasmo E, Pisani D |title=Primary hyperparathyroidism and osteoporosis |journal=Aging (Milano) |volume=10 |issue=3 |pages=225–31 |year=1998 |pmid=9801732 |doi= |url=}}</ref><ref name="pmid91583182">{{cite journal |vauthors=Spaulding CM, Young G |title=Osteitis fibrosa cystica and chronic renal failure |journal=J Am Podiatr Med Assoc |volume=87 |issue=5 |pages=238–40 |year=1997 |pmid=9158318 |doi=10.7547/87507315-87-5-238 |url=http://www.japmaonline.org/doi/10.7547/87507315-87-5-238?url_ver=Z39.88-2003&rfr_dat=cr_pub%3Dpubmed&rfr_id=ori:rid:crossref.org&code=pmas-site}}</ref><ref name="pmid3282282">{{cite journal |vauthors=Eastwood JB |title=Renal osteodystrophy--a radiological review |journal=CRC Crit Rev Diagn Imaging |volume=9 |issue=1 |pages=77–104 |year=1977 |pmid=328228 |doi= |url=}}</ref><ref name="pmid106334622">{{cite journal |vauthors=Adams JE |title=Renal bone disease: radiological investigation |journal=Kidney Int. Suppl. |volume=73 |issue= |pages=S38–41 |year=1999 |pmid=10633462 |doi= |url=}}</ref><ref name="pmid127142252">{{cite journal |vauthors=Jevtic V |title=Imaging of renal osteodystrophy |journal=Eur J Radiol |volume=46 |issue=2 |pages=85–95 |year=2003 |pmid=12714225 |doi= 10.1016/S0720-048X(03)00072-X|url=http://www.sciencedirect.com/science/article/pii/S0720048X0300072X?via%3Dihub}}</ref>
| style="background: #DCDCDC;" |
*[[Brown tumor]]
*[[Osteitis fibrosa cystica]]
*[[Osteoporosis]]
|-
! style="background: #F0FFFF; text-align: center;" |Neuromuscular complications
<ref name="pmid472342">{{cite journal |vauthors=Mallette LE, Patten BM, Engel WK |title=Neuromuscular disease in secondary hyperparathyroidism |journal=Ann. Intern. Med. |volume=82 |issue=4 |pages=474–83 |year=1975 |pmid=47234 |doi= |url=}}</ref><ref name="pmid6465552">{{cite journal |vauthors=Gerhardt RE, Zeitlin EL |title=Neuromuscular disease in tertiary hyperparathyroidism |journal=Arch. Intern. Med. |volume=138 |issue=6 |pages=1013–5 |year=1978 |pmid=646555 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Neuropathic]] [[muscle]] disease
|-
! style="background: #F0FFFF; text-align: center;" |Pregnancy related complications<ref name="pmid175699902">{{cite journal |vauthors=Poomthavorn P, Ongphiphadhanakul B, Mahachoklertwattana P |title=Transient neonatal hypoparathyroidism in two siblings unmasking maternal normocalcemic hyperparathyroidism |journal=Eur. J. Pediatr. |volume=167 |issue=4 |pages=431–4 |year=2008 |pmid=17569990 |doi=10.1007/s00431-007-0528-6 |url=}}</ref>
| style="background: #DCDCDC;" |
*Neonatal [[hypoparathyroidism]]
|-
! style="background: #F0FFFF; text-align: center;" |Psychiatric complications
<ref name="pmid193365052">{{cite journal |vauthors=Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S, Cosman F, Silverberg SJ |title=Neuropsychological features in primary hyperparathyroidism: a prospective study |journal=J. Clin. Endocrinol. Metab. |volume=94 |issue=6 |pages=1951–8 |year=2009 |pmid=19336505 |pmc=2690425 |doi=10.1210/jc.2008-2574 |url=}}</ref><ref name="pmid219178702">{{cite journal |vauthors=Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA |title=Depression in primary hyperparathyroidism: prevalence and benefit of surgery |journal=J. Clin. Endocrinol. Metab. |volume=96 |issue=11 |pages=E1737–45 |year=2011 |pmid=21917870 |doi=10.1210/jc.2011-1486 |url=}}</ref><ref name="pmid26085902">{{cite journal |vauthors=McAllion SJ, Paterson CR |title=Psychiatric morbidity in primary hyperparathyroidism |journal=Postgrad Med J |volume=65 |issue=767 |pages=628–31 |year=1989 |pmid=2608590 |pmc=2429194 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Anxiety]]
*[[Cognition|Cognitive]] dysfunction including verbal memory and nonverbal abstraction
*[[Depression]]
*[[Irritability]]
*Lack of concentration
*[[Sleep disturbances]]
|-
! style="background: #F0FFFF; text-align: center;" |Renal complications
<ref name="pmid124127833">{{cite journal |vauthors=Peacock M |title=Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum |journal=J. Bone Miner. Res. |volume=17 Suppl 2 |issue= |pages=N87–94 |year=2002 |pmid=12412783 |doi= |url=}}</ref><ref name="pmid224708642">{{cite journal |vauthors=Lila AR, Sarathi V, Jagtap V, Bandgar T, Menon PS, Shah NS |title=Renal manifestations of primary hyperparathyroidism |journal=Indian J Endocrinol Metab |volume=16 |issue=2 |pages=258–62 |year=2012 |pmid=22470864 |pmc=3313745 |doi=10.4103/2230-8210.93745 |url=}}</ref><ref name="pmid198088522">{{cite journal |vauthors=Tassone F, Gianotti L, Emmolo I, Ghio M, Borretta G |title=Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism |journal=J. Clin. Endocrinol. Metab. |volume=94 |issue=11 |pages=4458–61 |year=2009 |pmid=19808852 |doi=10.1210/jc.2009-0587 |url=}}</ref><ref name="pmid115908982">{{cite journal |vauthors=Kim H, Cheigh JS, Ham HW |title=Urinary stones following renal transplantation |journal=Korean J. Intern. Med. |volume=16 |issue=2 |pages=118–22 |year=2001 |pmid=11590898 |pmc=4531707 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Hypercalciuria]]
*[[Nephrolithiasis]]
*[[Nephrocalcinosis]]
*[[Renal insufficiency]] (impairement of [[Glomerular filtration rate|GFR]])
|-
! style="background: #F0FFFF; text-align: center;" |Rheumatologic complications
<ref name="pmid203057742">{{cite journal |vauthors=Michael JW, Schlüter-Brust KU, Eysel P |title=The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee |journal=Dtsch Arztebl Int |volume=107 |issue=9 |pages=152–62 |year=2010 |pmid=20305774 |pmc=2841860 |doi=10.3238/arztebl.2010.0152 |url=}}</ref><ref>{{cite book | last = Hochberg | first = Marc | title = Rheumatology|chapter=204. Primary hyperparathyroidism: rheumatologic manifestations and bone disease |page=1668| publisher = Mosby/Elsevier | location = Philadelphia, PA | year = 2015 | isbn = 9780323091381}}</ref><ref name="pmid118908842">{{cite journal |vauthors=Rubin MR, Silverberg SJ |title=Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy |journal=Curr Rheumatol Rep |volume=4 |issue=2 |pages=179–85 |year=2002 |pmid=11890884 |doi= |url=}}</ref><ref name="pmid27127942">{{cite journal |vauthors=Adler JS, Cameron DC |title=Erosive spondylo-arthropathy and tertiary hyperparathyroidism |journal=Australas Radiol |volume=33 |issue=1 |pages=90–2 |year=1989 |pmid=2712794 |doi= |url=}}</ref>
| style="background: #DCDCDC;" |
*[[Gout]]
*[[Osteoarthritis]]
*[[Pseudogout]]
|}
===Prognosis===
===Prognosis===
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
*Prognosis of parathyroid adenoma is generally excellent after [[parathyroidectomy]].
*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
*The complications of parathyroid adenoma resolves after the treatment.
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
*Untreated complication of parathyroid adenoma may be fatal.<ref name="pmid38780023">{{cite journal |vauthors=Corlew DS, Bryda SL, Bradley EL, DiGirolamo M |title=Observations on the course of untreated primary hyperparathyroidism |journal=Surgery |volume=98 |issue=6 |pages=1064–71 |year=1985 |pmid=3878002 |doi= |url=}}</ref>
*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.


==References==
==References==

Revision as of 13:19, 3 June 2019

Parathyroid adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Parathyroid Adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Parathyroid adenoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Parathyroid adenoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Parathyroid adenoma natural history, complications and prognosis

CDC on Parathyroid adenoma natural history, complications and prognosis

Parathyroid adenoma natural history, complications and prognosis in the news

Blogs on Parathyroid adenoma natural history, complications and prognosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Parathyroid adenoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Natural History, Complications, and Prognosis

Natural History

Complications

Organ system specific complication caused by primary hyperparathyroidism due to parathyroid adenoma include:

Complications involving Organ system Complications due to Primary Hyperparathyroidism
Cardiaovascular complications

[3][4]

Endocrine complications[5]
Gastrointestinal complications[6]
Metabolic complications

[7][8][6][9][10][11][12]

Musculo-skeletal complications

[13][14][15][16][17][18]

Neuromuscular complications

[19][20]

Pregnancy related complications[21]
Psychiatric complications

[22][23][24]

Renal complications

[25][26][27][28]

Rheumatologic complications

[29][30][31][32]

Prognosis

  • Prognosis of parathyroid adenoma is generally excellent after parathyroidectomy.
  • The complications of parathyroid adenoma resolves after the treatment.
  • Untreated complication of parathyroid adenoma may be fatal.[33]

References

  1. ↑ Peacock M (2002). "Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum". J. Bone Miner. Res. 17 Suppl 2: N87–94. PMID 12412783.
  2. ↑ Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV (1989). "Skeletal disease in primary hyperparathyroidism". J. Bone Miner. Res. 4 (3): 283–91. doi:10.1002/jbmr.5650040302. PMID 2763869.
  3. ↑ Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B (1997). "Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up". J. Clin. Endocrinol. Metab. 82 (1): 106–12. doi:10.1210/jcem.82.1.3666. PMID 8989242.
  4. ↑ Strózecki P, Adamowicz A, Nartowicz E, Odrowaz-Sypniewska G, Włodarczyk Z, Manitius J (2001). "Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients". Ren Fail. 23 (1): 115–26. PMID 11256521.
  5. ↑ Bai HX, Giefer M, Patel M, Orabi AI, Husain SZ (2012). "The association of primary hyperparathyroidism with pancreatitis". J. Clin. Gastroenterol. 46 (8): 656–61. doi:10.1097/MCG.0b013e31825c446c. PMC 4428665. PMID 22874807.
  6. ↑ 6.0 6.1 Corlew DS, Bryda SL, Bradley EL, DiGirolamo M (1985). "Observations on the course of untreated primary hyperparathyroidism". Surgery. 98 (6): 1064–71. PMID 3878002.
  7. ↑ Fitzpatrick LA, Bilezikian JP (1987). "Acute primary hyperparathyroidism". Am. J. Med. 82 (2): 275–82. PMID 3812520.
  8. ↑ Ahmad S, Kuraganti G, Steenkamp D (2015). "Hypercalcemic crisis: a clinical review". Am. J. Med. 128 (3): 239–45. doi:10.1016/j.amjmed.2014.09.030. PMID 25447624.
  9. ↑ Lips P (2001). "Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications". Endocr Rev. 22 (4): 477–501. doi:10.1210/edrv.22.4.0437. PMID 11493580.
  10. ↑ Saab G, Whaley-Connell A, Bombeck A, Kurella Tamura M, Li S, Chen SC, McFarlane SI, Sowers JR, Norris K, Bakris GL, McCullough PA (2011). "The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease". Cardiorenal Med. 1 (2): 123–130. doi:10.1159/000327149. PMC 3101512. PMID 22258399.
  11. ↑ Hjelmesæth, Jøran; Hofsø, Dag; Aasheim, Erlend T; Jenssen, Trond; Moan, Johan; Hager, Helle; Røislien, Jo; Bollerslev, Jens (2009). "Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study". Cardiovascular Diabetology. 8 (1): 7. doi:10.1186/1475-2840-8-7. ISSN 1475-2840.
  12. ↑ Barbur MA, Kurjak M, Becker K (1997). "[Systematic calciphylaxis in chronic renal failure: fulminant course after kidney transplantation]". Pathologe (in German). 18 (6): 453–8. PMID 9451734.
  13. ↑ Bandeira F, Cusano NE, Silva BC, Cassibba S, Almeida CB, Machado VC, Bilezikian JP (2014). "Bone disease in primary hyperparathyroidism". Arq Bras Endocrinol Metabol. 58 (5): 553–61. PMC 4315357. PMID 25166047.
  14. ↑ Mazzuoli GF, D'Erasmo E, Pisani D (1998). "Primary hyperparathyroidism and osteoporosis". Aging (Milano). 10 (3): 225–31. PMID 9801732.
  15. ↑ Spaulding CM, Young G (1997). "Osteitis fibrosa cystica and chronic renal failure". J Am Podiatr Med Assoc. 87 (5): 238–40. doi:10.7547/87507315-87-5-238. PMID 9158318.
  16. ↑ Eastwood JB (1977). "Renal osteodystrophy--a radiological review". CRC Crit Rev Diagn Imaging. 9 (1): 77–104. PMID 328228.
  17. ↑ Adams JE (1999). "Renal bone disease: radiological investigation". Kidney Int. Suppl. 73: S38–41. PMID 10633462.
  18. ↑ Jevtic V (2003). "Imaging of renal osteodystrophy". Eur J Radiol. 46 (2): 85–95. doi:10.1016/S0720-048X(03)00072-X. PMID 12714225.
  19. ↑ Mallette LE, Patten BM, Engel WK (1975). "Neuromuscular disease in secondary hyperparathyroidism". Ann. Intern. Med. 82 (4): 474–83. PMID 47234.
  20. ↑ Gerhardt RE, Zeitlin EL (1978). "Neuromuscular disease in tertiary hyperparathyroidism". Arch. Intern. Med. 138 (6): 1013–5. PMID 646555.
  21. ↑ Poomthavorn P, Ongphiphadhanakul B, Mahachoklertwattana P (2008). "Transient neonatal hypoparathyroidism in two siblings unmasking maternal normocalcemic hyperparathyroidism". Eur. J. Pediatr. 167 (4): 431–4. doi:10.1007/s00431-007-0528-6. PMID 17569990.
  22. ↑ Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S, Cosman F, Silverberg SJ (2009). "Neuropsychological features in primary hyperparathyroidism: a prospective study". J. Clin. Endocrinol. Metab. 94 (6): 1951–8. doi:10.1210/jc.2008-2574. PMC 2690425. PMID 19336505.
  23. ↑ Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA (2011). "Depression in primary hyperparathyroidism: prevalence and benefit of surgery". J. Clin. Endocrinol. Metab. 96 (11): E1737–45. doi:10.1210/jc.2011-1486. PMID 21917870.
  24. ↑ McAllion SJ, Paterson CR (1989). "Psychiatric morbidity in primary hyperparathyroidism". Postgrad Med J. 65 (767): 628–31. PMC 2429194. PMID 2608590.
  25. ↑ Peacock M (2002). "Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum". J. Bone Miner. Res. 17 Suppl 2: N87–94. PMID 12412783.
  26. ↑ Lila AR, Sarathi V, Jagtap V, Bandgar T, Menon PS, Shah NS (2012). "Renal manifestations of primary hyperparathyroidism". Indian J Endocrinol Metab. 16 (2): 258–62. doi:10.4103/2230-8210.93745. PMC 3313745. PMID 22470864.
  27. ↑ Tassone F, Gianotti L, Emmolo I, Ghio M, Borretta G (2009). "Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism". J. Clin. Endocrinol. Metab. 94 (11): 4458–61. doi:10.1210/jc.2009-0587. PMID 19808852.
  28. ↑ Kim H, Cheigh JS, Ham HW (2001). "Urinary stones following renal transplantation". Korean J. Intern. Med. 16 (2): 118–22. PMC 4531707. PMID 11590898.
  29. ↑ Michael JW, Schlüter-Brust KU, Eysel P (2010). "The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee". Dtsch Arztebl Int. 107 (9): 152–62. doi:10.3238/arztebl.2010.0152. PMC 2841860. PMID 20305774.
  30. ↑ Hochberg, Marc (2015). "204. Primary hyperparathyroidism: rheumatologic manifestations and bone disease". Rheumatology. Philadelphia, PA: Mosby/Elsevier. p. 1668. ISBN 9780323091381.
  31. ↑ Rubin MR, Silverberg SJ (2002). "Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy". Curr Rheumatol Rep. 4 (2): 179–85. PMID 11890884.
  32. ↑ Adler JS, Cameron DC (1989). "Erosive spondylo-arthropathy and tertiary hyperparathyroidism". Australas Radiol. 33 (1): 90–2. PMID 2712794.
  33. ↑ Corlew DS, Bryda SL, Bradley EL, DiGirolamo M (1985). "Observations on the course of untreated primary hyperparathyroidism". Surgery. 98 (6): 1064–71. PMID 3878002.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Parathyroid_adenoma_natural_history,_complications_and_prognosis&oldid=1570726"